Literature DB >> 27294250

Lessons learned from 2 decades of CAP therapy data: ways to improve patient management.

Michael T Bender1, Michael S Niederman1.   

Abstract

Entities:  

Year:  2016        PMID： 27294250      PMCID： PMC4885979          DOI： 10.21037/jtd.2016.04.36

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

Review 1.  Antibiotic Therapy for Adults Hospitalized With Community-Acquired Pneumonia: A Systematic Review.

Authors:  Jonathan S Lee; Daniel L Giesler; Walid F Gellad; Michael J Fine
Journal:  JAMA       Date:  2016-02-09       Impact factor: 56.272

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Antibiotic treatment strategies for community-acquired pneumonia in adults.

Authors:  Douwe F Postma; Cornelis H van Werkhoven; Leontine J R van Elden; Steven F T Thijsen; Andy I M Hoepelman; Jan A J W Kluytmans; Wim G Boersma; Clara J Compaijen; Eva van der Wall; Jan M Prins; Jan J Oosterheert; Marc J M Bonten
Journal:  N Engl J Med       Date:  2015-04-02       Impact factor: 91.245

4.  Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial.

Authors:  Jordi Carratalà; Carolina Garcia-Vidal; Lucía Ortega; Núria Fernández-Sabé; Mercedes Clemente; Ginesa Albero; Marta López; Xavier Castellsagué; Jordi Dorca; Ricard Verdaguer; Joaquín Martínez-Montauti; Frederic Manresa; Francesc Gudiol
Journal:  Arch Intern Med       Date:  2012-06-25

Review 5.  Burden of community-acquired pneumonia in North American adults.

Authors:  Thomas M File; Thomas J Marrie
Journal:  Postgrad Med       Date:  2010-03       Impact factor: 3.840

6.  Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia.

Authors:  I Martin-Loeches; T Lisboa; A Rodriguez; C Putensen; D Annane; J Garnacho-Montero; M I Restrepo; J Rello
Journal:  Intensive Care Med       Date:  2009-12-02       Impact factor: 17.440

7.  Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.

Authors:  Richard B Brown; Paul Iannini; Peter Gross; Mark Kunkel
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

8.  Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia.

Authors:  Eric M Mortensen; Ethan A Halm; Mary Jo Pugh; Laurel A Copeland; Mark Metersky; Michael J Fine; Christopher S Johnson; Carlos A Alvarez; Christopher R Frei; Chester Good; Marcos I Restrepo; John R Downs; Antonio Anzueto
Journal:  JAMA       Date:  2014-06-04       Impact factor: 56.272

9.  The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia.

Authors:  Steven Fishbane; Michael S Niederman; Colleen Daly; Adam Magin; Masateru Kawabata; André de Corla-Souza; Irum Choudhery; Gerald Brody; Maureen Gaffney; Simcha Pollack; Suzanne Parker
Journal:  Arch Intern Med       Date:  2007 Aug 13-27

10.  Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.

Authors:  J A Ramirez; L Srinath; S Ahkee; A Huang; M J Raff
Journal:  Arch Intern Med       Date:  1995-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.